BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9192542)

  • 1. Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
    Bunker MT; Marken PA; Schneiderhan ME; Ruehter VL
    J Child Adolesc Psychopharmacol; 1997; 7(1):65-9. PubMed ID: 9192542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
    Smith S
    J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bromocriptine on neuroleptic-induced amenorrhea, galactorrhea and impotence.
    Matsuoka I; Nakai T; Miyake M; Hirai M; Ikawa G
    Jpn J Psychiatry Neurol; 1986 Dec; 40(4):639-46. PubMed ID: 2885437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T; Bonsack C
    Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
    Keller R; Mongini F
    Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine-induced hyperprolactinemia and galactorrhea reversed with addition of bromocriptine: a case report.
    Miller DE; Sebastian CS
    J Clin Psychiatry; 2005 Feb; 66(2):269-70. PubMed ID: 15705020
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
    Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis associated with neuroleptic treatment. A case report.
    Kartaginer J; Ataya K; Mercado A; Abbasi A
    J Reprod Med; 1990 Feb; 35(2):198-202. PubMed ID: 1968102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
    Gioia P; Asnis G
    J Clin Psychiatry; 1988 Jan; 49(1):29-31. PubMed ID: 2891689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

  • 12. Aripiprazole for the treatment of duloxetine-induced hyperprolactinemia: A case report.
    Luo T; Liu QS; Yang YJ; Wei B
    J Affect Disord; 2019 May; 250():330-332. PubMed ID: 30875676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of bromocriptine mesylate on induced hyperprolactinemia in stabilized psychiatric outpatients undergoing neuroleptic treatment.
    Cohn JB; Brust J; DiSerio F; Singer J
    Neuropsychobiology; 1985; 13(4):173-9. PubMed ID: 4047382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotic exacerbation attributed to low-dose bromocriptine treatment of galactorrhea and hyperprolactinemia.
    Dorevitch A; Aronzon R; Stark M
    Acta Obstet Gynecol Scand; 1991; 70(4-5):375-6. PubMed ID: 1746267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of psychotropic-induced hyperprolactinemia.
    Marken PA; Haykal RF; Fisher JN
    Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
    Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperprolactinemia in mentally ill patients].
    Carvalho MM; Góis C
    Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Galactorrhea and secondary amenorrhea in hyperprolactinemia].
    Wallmeroth A; Staub JJ
    Praxis (Bern 1994); 2000 Aug; 89(34):1341-3. PubMed ID: 11021189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.